Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

721 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes.
Lim SM, Chang H, Yoon MJ, Hong YK, Kim H, Chung WY, Park CS, Nam KH, Kang SW, Kim MK, Kim SB, Lee SH, Kim HG, Na II, Kim YS, Choi MY, Kim JG, Park KU, Yun HJ, Kim JH, Cho BC. Lim SM, et al. Among authors: cho bc. Ann Oncol. 2013 Dec;24(12):3089-94. doi: 10.1093/annonc/mdt379. Epub 2013 Sep 19. Ann Oncol. 2013. PMID: 24050953 Free article. Clinical Trial.
Immunotherapy in the treatment of non-small cell lung cancer.
Sundar R, Soong R, Cho BC, Brahmer JR, Soo RA. Sundar R, et al. Among authors: cho bc. Lung Cancer. 2014 Aug;85(2):101-9. doi: 10.1016/j.lungcan.2014.05.005. Epub 2014 May 14. Lung Cancer. 2014. PMID: 24880938 Free PMC article. Review.
Safety and efficacy of dacomitinib in korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: a phase I/II trial.
Park K, Cho BC, Kim DW, Ahn MJ, Lee SY, Gernhardt D, Taylor I, Campbell AK, Zhang H, Giri N, Letrent SP, O'Connell J, Heo DS. Park K, et al. Among authors: cho bc. J Thorac Oncol. 2014 Oct;9(10):1523-31. doi: 10.1097/JTO.0000000000000275. J Thorac Oncol. 2014. PMID: 25521398 Free article. Clinical Trial.
Nivolumab in NSCLC: latest evidence and clinical potential.
Sundar R, Cho BC, Brahmer JR, Soo RA. Sundar R, et al. Among authors: cho bc. Ther Adv Med Oncol. 2015 Mar;7(2):85-96. doi: 10.1177/1758834014567470. Ther Adv Med Oncol. 2015. PMID: 25755681 Free PMC article. Review.
721 results